About Östersund Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Östersund Hospital
During the past decade, Östersund Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
2021-05-04
2034-10-26
Recruiting
1,700
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
2021-08-27
2033-11-21
Recruiting
4,100
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Östersund Hospital" #1 sponsor was "Umeå University" with 8 trials, followed by "Amgen" with 2 trials
sponsored, "Karolinska Institutet" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Anders Svenningsson"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Östersund Hospital"
#1 collaborator was "Karolinska University Hospital" with 2 trials as a collaborator, "Linkoeping University" with 2 trials as a collaborator, "Region Jämtland Härjedalen" with 2 trials as a collaborator, "Uppsala University" with 2 trials as a collaborator and "Västerbotten County Council, Sweden" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were
collaborators in the rest 35 trials.
Clinical Trials Conditions at Östersund Hospital
According to Clinical.Site data, the most researched conditions in "Östersund Hospital" are
"Cardiovascular Disease" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials) and "Acute Vestibular Syndrome" (1 trials). Many other conditions were trialed in "Östersund Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Östersund Hospital
Most popular intervention types in "Östersund Hospital" are "Drug" (14 trials), "Procedure" (6 trials), "Other" (5 trials) and "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Evolocumab" (2 trials), "Rituximab" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Östersund Hospital
The vast majority of trials in "Östersund Hospital" are
20 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Östersund Hospital
Currently, there are NaN active trials in "Östersund Hospital".
undefined are not yet recruiting,
6 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Östersund Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Östersund Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 10 trials that are defined as “Not Applicable".